Skip to main content
SpringerLink
Log in

Concerns about the long-term safety of live kidney donors are justified

  • COMMENTARY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ratner LE, Ciseck LJ, Moore RG, Cigarroa FG, Kaufman HS, Kavoussi LR. Laparoscopic live donor nephrectomy. Transplantation. 1995;60(9):1047–9.

    CAS  PubMed  Google Scholar 

  2. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol JASN. 2001;12(6):1315–25.

    CAS  PubMed  Google Scholar 

  3. Kasiske BL, Anderson-Haag T, Israni AK, Kalil RS, Kimmel PL, Kraus ES, et al. A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis. 2015;66(1):114–24.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–31.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Poggio ED, Braun WE, Davis C. The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation–evaluation, determinants, and implications for outcomes. Clin J Am Soc Nephrol CJASN. 2009;4(10):1677–84.

    Article  PubMed  Google Scholar 

  6. Fehrman-Ekholm I, Norden G, Lennerling A, Rizell M, Mjornstedt L, Wramner L, et al. Incidence of end-stage renal disease among live kidney donors. Transplantation. 2006;82(12):1646–8.

    Article  PubMed  Google Scholar 

  7. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, et al. Long-term consequences of kidney donation. N Engl J Med. 2009;360(5):459–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cherikh WS, Young CJ, Kramer BF, Taranto SE, Randall HB, Fan PY. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transpl. 2011;11(8):1650–5.

    Article  CAS  Google Scholar 

  9. Mjoen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Oyen O, et al. Long-term risks for kidney donors. Kidney Int. 2014;86(1):162–7.

    Article  PubMed  Google Scholar 

  10. Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311(6):579–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Boudville N, Garg AX. End-stage renal disease in living kidney donors. Kidney Int. 2014;86(1):20–2.

    Article  PubMed  Google Scholar 

  12. Gill JS, Tonelli M. Understanding rare adverse outcomes following living kidney donation. JAMA. 2014;311(6):577–9.

    Article  CAS  PubMed  Google Scholar 

  13. Kiberd B, Tennankore K. Kidney donation and risk of ESRD. JAMA. 2014;312(1):93.

    Article  CAS  PubMed  Google Scholar 

  14. Matas AJ, Wadstrom J, Ibrahim HN. Kidney donation and risk of ESRD. JAMA. 2014;312(1):92–3.

    Article  CAS  PubMed  Google Scholar 

  15. Niemi M, Mandelbrot DA. Kidney donation and risk of ESRD. JAMA. 2014;312(1):92.

    Article  PubMed  Google Scholar 

  16. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21(4):387–93.

    Article  CAS  PubMed  Google Scholar 

  17. Spray BJ, Atassi NG, Tuttle AB, Freedman BI. Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol JASN. 1995;5(10):1806–10.

    CAS  PubMed  Google Scholar 

  18. Delmonico F. Council of the transplantation S. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation. 2005;79(6 Suppl):53–66.

    Google Scholar 

  19. Janki S, Steyerberg EW, Hofman A, JN IJ. Live kidney donation: are concerns about long-term safety justified?—a methodological review. Eur J Epidemiol. 2016. doi:10.1007/s10654-016-0168-0.

  20. Matas AJ, Hays RE, Ibrahim HN. Long-term non-end-stage renal disease risks after living kidney donation. Am J Transpl. 2016. doi:10.1111/ajt.14011.

  21. Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303(10):959–66.

    Article  CAS  PubMed  Google Scholar 

  22. Garg AX, Meirambayeva A, Huang A, Kim J, Prasad GV, Knoll G, et al. Cardiovascular disease in kidney donors: matched cohort study. BMJ. 2012;344:e1203.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mjoen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, et al. Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transpl. 2012;27(1):443–7.

    Article  Google Scholar 

  24. Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, et al. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med. 2015;372(2):124–33.

    Article  CAS  PubMed  Google Scholar 

  25. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–69.

    Article  PubMed  Google Scholar 

  26. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–25.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9.

    Article  CAS  PubMed  Google Scholar 

  28. Vikse BE, Hallan S, Bostad L, Leivestad T, Iversen BM. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol Dial Transpl. 2010;25(10):3289–96.

    Article  Google Scholar 

  29. Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Commun Health. 2004;58(8):635–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Abimereki D. Muzaale, Allan B. Massie & Dorry L. Segev

  2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Allan B. Massie & Dorry L. Segev

Authors
  1. Abimereki D. Muzaale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allan B. Massie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dorry L. Segev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dorry L. Segev.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muzaale, A.D., Massie, A.B. & Segev, D.L. Concerns about the long-term safety of live kidney donors are justified. Eur J Epidemiol 32, 91–93 (2017). https://doi.org/10.1007/s10654-017-0241-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-017-0241-3

Keywords

Search

Navigation